Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
- PMID: 26649581
- DOI: 10.1097/SLA.0000000000001442
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?
Abstract
Background data: In compensated cirrhotics with early hepatocellular carcinoma (HCC-cirr), upfront liver resection (LR) and salvage liver transplantation (SLT) in case of recurrence may have outcomes comparable to primary LT (PLT).
Objective: An intention-to-treat (ITT) analysis comparing PLT and SLT strategies.
Methods: Of 130 HCC-cirr patients who underwent upfront LR (group LR), 90 (69%) recurred, 31 could undergo SLT (group SLT). During the same period, 366 patients were listed for LT (group LLT); 26 dropped-out (7.1%), 340 finally underwent PLT (group PLT). We compared survival between groups LR and LLT, LR and PLT, and PLT and SLT.
Results: Feasibility of SLT strategy was 34% (31/90). In an ITT analysis, group LLT had better 5-yr/10-yr overall survival (OS) compared with group LR (68%/58% vs. 58%/35%; P = 0.008). Similarly, 5-yr/10-yr OS and disease-free survival (DFS) were better in group PLT versus group LR (OS 73%/63% vs. 58%/35%, P = 0.0007; DFS 69%/61% vs. 27%/21%, P < 0.0001). Upfront resection and microvascular tumor invasion were poor prognostic factors for both OS and DFS, presence of satellite tumor nodules additionally predicted worse DFS. Group SLT had similar postoperative and long-term outcomes compared with group PLT (starting from time of LT) (OS 54%/54% vs. 73%/63%, P = 0.35; DFS 48%/48% vs. 69%/61%, P = 0.18, respectively).
Conclusions: In initially transplantable HCC-cirr patients, ITT survival was better in group PLT compared with group LR. SLT was feasible in only a third of patients who recurred after LR. Post SLT, short and long-term outcomes were comparable with PLT. Better patient selection for the "resection first" approach and early detection of recurrence may improve outcomes of the SLT strategy.
Comment in
-
[Transplantation strategies for hepatocellular carcinoma].Chirurg. 2016 Oct;87(10):890. doi: 10.1007/s00104-016-0285-z. Chirurg. 2016. PMID: 27555057 German. No abstract available.
Similar articles
-
Results of salvage liver transplantation.Liver Int. 2014 Jul;34(6):e96-e104. doi: 10.1111/liv.12497. Epub 2014 Mar 12. Liver Int. 2014. PMID: 24517642
-
Salvage liver transplantation or repeat hepatectomy for recurrent hepatocellular carcinoma: An intent-to-treat analysis.Liver Transpl. 2017 Dec;23(12):1553-1563. doi: 10.1002/lt.24952. Liver Transpl. 2017. PMID: 28945955
-
Salvage Liver Transplant versus Primary Liver Transplant for Patients with Hepatocellular Carcinoma.Ann Transplant. 2018 Aug 3;23:524-545. doi: 10.12659/AOT.908623. Ann Transplant. 2018. PMID: 30072683 Free PMC article.
-
Liver transplantation versus liver resection for hepatocellular carcinoma in intention to treat: An attempt to perform an ideal meta-analysis.Liver Transpl. 2017 Jun;23(6):836-844. doi: 10.1002/lt.24758. Liver Transpl. 2017. PMID: 28295992 Review.
-
Comparison Between Salvage Liver Transplantation and Repeat Liver Resection for Recurrent Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.Transplant Proc. 2019 Mar;51(2):433-436. doi: 10.1016/j.transproceed.2019.01.072. Epub 2019 Jan 29. Transplant Proc. 2019. PMID: 30879559
Cited by
-
Adrenalectomy for solitary recurrent hepatocellular carcinoma five years after living donor liver transplantation: A case report.Int J Surg Case Rep. 2019;54:23-27. doi: 10.1016/j.ijscr.2018.11.062. Epub 2018 Nov 27. Int J Surg Case Rep. 2019. PMID: 30513494 Free PMC article.
-
Appropriate treatment modality for solitary small hepatocellular carcinoma: Radiofrequency ablation vs. resection vs. transplantation?Clin Mol Hepatol. 2019 Dec;25(4):354-359. doi: 10.3350/cmh.2018.0096. Epub 2019 Apr 22. Clin Mol Hepatol. 2019. PMID: 31006225 Free PMC article. Review.
-
Integrative Concepts for Liver Surgery.Visc Med. 2020 Oct;36(5):351-358. doi: 10.1159/000511043. Epub 2020 Sep 17. Visc Med. 2020. PMID: 33178731 Free PMC article. Review.
-
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy.Front Oncol. 2020 Dec 17;10:574668. doi: 10.3389/fonc.2020.574668. eCollection 2020. Front Oncol. 2020. PMID: 33425729 Free PMC article.
-
Outcomes of liver transplantation of hepatoblastoma: single-center data in mainland China.Front Pediatr. 2025 Feb 21;13:1502761. doi: 10.3389/fped.2025.1502761. eCollection 2025. Front Pediatr. 2025. PMID: 40061426 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical